Over-the-counter (OTC) or off-exchange trading is done directly between two parties, without the supervision of an exchange.

A dietary supplement is a manufactured product intended to supplement the diet when taken by mouth as a pill, capsule, tablet, or liquid.[2] A supplement can provide nutrients either extracted from food sources or synthetic, individually or in combination, in order to increase the quantity of their consumption. The class of nutrient compounds includes vitamins, minerals, fiber, fatty acids and amino acids. Dietary supplements can also contain substances that have not been confirmed as being essential to life, but are marketed as having a beneficial biological effect, such as plant pigments or polyphenols.
Based on the Over the Counter (OTC) & Diet Supplementary market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and comprehensive competitive strategy analysis in different fields. From the competitive advantages of different types of products and services, the development opportunities and consumption characteristics and structure analysis of the downstream application fields are all analyzed in detail. To Boost Growth during the epidemic era, this report analyzes in detail for the potential risks and opportunities which can be focused on.

In Chapter 2.4 of the report, we share our perspectives for the impact of COVID-19 from the long and short term.
In chapter 3.4, we provide the influence of the crisis on the industry chain, especially for marketing channels.
In chapters 8-13, we update the timely industry economic revitalization plan of the country-wise government.

Key players in the global Over the Counter (OTC) & Diet Supplementary market covered in Chapter 5:
Sanofi S.A
GlaxoSmithKline plc.
Johnson & Johnson
Merck KGaA.
Roche Holding AG
Merck & Co., Inc.
Pfizer Inc.
Herblife Ltd.
AstraZeneca plc.
Croda
Gilead Sciences
Novartis International AG.
Bayer Healthcare AG

In Chapter 6, on the basis of types, the Over the Counter (OTC) & Diet Supplementary market from 2015 to 2025 is primarily split into:
Analgesic & pain relievers
Dermatological products
Cough, cold, and flu products
Vitamin Supplements
Mineral Supplements
Ophthalmic Products

In Chapter 7, on the basis of applications, the Over the Counter (OTC) & Diet Supplementary market from 2015 to 2025 covers:
Hospital
Clinic
Others

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 8-13:
North America (Covered in Chapter 9)
United States
Canada
Mexico
Europe (Covered in Chapter 10)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 11)
China
Japan
South Korea
Australia
India
South America (Covered in Chapter 12)
Brazil
Argentina
Columbia
Middle East and Africa (Covered in Chapter 13)
UAE
Egypt
South Africa

Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025